# Drug-Drug Interaction Study of Atumelnant in Healthy Participants

> **NCT07570082** · PHASE1 · RECRUITING · sponsor: **Crinetics Pharmaceuticals Inc.** · enrollment: 46 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Atumelnant
- **DRUG:** Carbamazepine
- **DRUG:** Midazolam
- **DRUG:** Digoxin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT07570082
- **Lead sponsor:** Crinetics Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07570082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07570082, "Drug-Drug Interaction Study of Atumelnant in Healthy Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07570082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*